glp-1 stocks How medications are transforming diabetes and weight loss treatment Boom in GLP-1 drugs augurs
Description
Introduction Cardiovascular disease (CVD) is the main cause of morbidity and mortality in patients with type 2 diabetes (T2DM), with a relevant impact on the economic costs for health care systems and on the quality of life for many patients (1, 2)
Misleading marketing preys on consumers trust, making it essential to rely on clinically proven treatments for safe and effective weight loss
BMC Nutr
We also dont know much about the relative effects of weight loss on mortality
Tirzepatide with glycine and B12 combines metabolic support with GI-friendly amino acids
Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG
